MAGELLAN HEALTH INC (MGLN) Stock Analyst Earnings Estimates
NASDAQ:MGLN - Nasdaq - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.958B -15.09% | 4.566B -7.91% | 4.578B 0.26% | 5.002B 9.28% | 5.401B 7.96% | 5.881B 8.90% | 6.252B 6.31% | 6.78B 8.43% | |
| EBITDA YoY % growth | 196.6M -27.45% | 182.3M -7.27% | 148.5M -18.54% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 63.9M -58.85% | 50.8M -20.50% | 29.8M -41.34% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 1.29% | 1.11% | 0.65% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 2.41 -56.34% | 3.73 54.77% | 1.69 -54.69% | 1.88 11.05% | 3.48 85.33% | 4.28 23.17% | 6.48 51.22% | 9.99 54.25% |
| Q4 / 21 | Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.39 202.00% | 1.13 -14.87% | 0.70 535.18% | 0.83 2,671.00% | 0.63 63.16% |
| Revenue Q2Q % growth | 1.293B 9.10% | 1.289B 10.97% | 1.336B 9.46% | 1.381B 10.08% | 1.423B 10.07% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 0.03 -62.50% | 0.38 | -0.35 | -92.05% |
| Q2 2021 Q2Q % growth | 0.11 -86.90% | 0.96 | -0.85 | -88.59% |
| Q1 2021 Q2Q % growth | 1.33 15.65% | 0.68 | 0.65 | 94.62% |
| Q4 2020 Q2Q % growth | -0.38 -130.65% | -0.26 | -0.12 | -48.43% |
| Q3 2020 Q2Q % growth | 0.08 -93.50% | -0.11 | 0.19 | 175.90% |
| Q2 2020 Q2Q % growth | 0.84 -2.33% | 0.84 | 0.00 | 0.02% |
| Q1 2020 Q2Q % growth | 1.15 187.50% | 0.73 | 0.42 | 56.66% |
| Q4 2019 Q2Q % growth | 1.24 | 0.99 | 0.25 | 24.69% |
| Q3 2019 Q2Q % growth | 1.23 | 1.34 | -0.11 | -7.95% |
| Q2 2019 Q2Q % growth | 0.86 | 0.94 | -0.08 | -8.35% |
| Q1 2019 Q2Q % growth | 0.40 | 0.57 | -0.17 | -29.28% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 1.254B 7.18% | 1.231B | 23.009M | 1.87% |
| Q2 2021 Q2Q % growth | 1.221B 10.97% | 1.167B | 54.23M | 4.65% |
| Q1 2021 Q2Q % growth | 1.162B 3.49% | 1.164B | -2.22M | -0.19% |
| Q4 2020 Q2Q % growth | 1.185B 4.52% | 1.16B | 25.451M | 2.19% |
| Q3 2020 Q2Q % growth | 1.17B 1.00% | 1.164B | 5.765M | 0.50% |
| Q2 2020 Q2Q % growth | 1.1B -4.70% | 1.05B | 50.429M | 4.80% |
| Q1 2020 Q2Q % growth | 1.122B 0.30% | 1.832B | -709.214M | -38.72% |
| Q4 2019 Q2Q % growth | 1.134B | 1.87B | -736.268M | -39.37% |
| Q3 2019 Q2Q % growth | 1.159B | 1.837B | -678.168M | -36.92% |
| Q2 2019 Q2Q % growth | 1.154B | 1.786B | -631.525M | -35.36% |
| Q1 2019 Q2Q % growth | 1.119B | 1.773B | -654.404M | -36.90% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |